-
1
المؤلفون: Shenhong Wu, Sherise Chantell Rogers, Christine A. Garcia
المصدر: Cancer Investigation. 35:552-561
مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Antineoplastic Agents, Pharmacology, Placebo, Risk Assessment, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Neoplasms, Internal medicine, medicine, Humans, Everolimus, 030212 general & internal medicine, Adverse effect, Randomized Controlled Trials as Topic, Chemotherapy, business.industry, General Medicine, Discontinuation, Oncology, 030220 oncology & carcinogenesis, Concomitant, Relative risk, Female, business, medicine.drug
-
2
المصدر: Journal of the National Medical Association. 109(1)
مصطلحات موضوعية: congenital, hereditary, and neonatal diseases and abnormalities, Pathology, medicine.medical_specialty, Receptor, ErbB-2, medicine.medical_treatment, Hamartoma, Breast Neoplasms, Malignancy, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, Breast Diseases, 0302 clinical medicine, Breast cancer, Biopsy, medicine, Humans, Neoplasm Invasiveness, Breast, Molecular Targeted Therapy, Precision Medicine, skin and connective tissue diseases, neoplasms, Neoplasm Staging, medicine.diagnostic_test, business.industry, Lumpectomy, Carcinoma, Ductal, Breast, General Medicine, Middle Aged, medicine.disease, Prognosis, 030220 oncology & carcinogenesis, Invasive lobular carcinoma, Female, Hormone therapy, business, Calcification, Mammography
-
3
المصدر: Blood. 128:5418-5418
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Pathology, Cyclophosphamide, business.industry, Immunology, Perforation (oil well), Cell Biology, Hematology, medicine.disease, Biochemistry, Lymphoma, 03 medical and health sciences, 0302 clinical medicine, Prednisone, 030220 oncology & carcinogenesis, Internal medicine, medicine, Rituximab, EPOCH (chemotherapy), business, Diffuse large B-cell lymphoma, Etoposide, 030215 immunology, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e90f43ca72813c792e6271fb5d677276
https://doi.org/10.1182/blood.v128.22.5418.5418 -
4
المؤلفون: Shenhong Wu, Sherise Chantell Rogers, Christine Ann Garcia
المصدر: Journal of Clinical Oncology. 34:e14020-e14020
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Everolimus, business.industry, Cancer, medicine.disease, Discontinuation, Internal medicine, medicine, business, Adverse effect, PI3K/AKT/mTOR pathway, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c9b992d5f3c449105c029a6acd64c5f7
https://doi.org/10.1200/jco.2016.34.15_suppl.e14020